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ABSTRACT
Objective. To study the frequency and 
features of joint and tendon involve-
ment in the hand of patients with pri-
mary Sjögren’s syndrome (pSS) by 
musculoskeletal ultrasound (US) exam-
ination.
Methods. Forty-eight patients with pSS 
diagnosed according to the preliminary 
classification criteria proposed by the 
American-European Classification Cri-
teria Group were enrolled in the study. 
Bilateral US examination of the 1st – 5th 
metacarpophalangeal (MCP), 2nd – 5th 
proximal interphalangeal (PIP) joints 
and of flexor tendons were performed. 
A semi-quantitative grading method (0 
to 3) for scoring joint effusion, synovial 
proliferation and intra-articular power 
Doppler (PD) signal was used.
Results. We observed clear evidence 
of inflammatory arthritis in 9 (18.7%) 
patients. Bone erosions at MCP and/
or PIP joint were visualized in 6 out 
of 48 (12.5%) patients. In 10 (20.8%) 
patients we imaged flexor tenosynovitis 
which appeared more frequent than in 
healthy subjects even if no statistically 
significant difference was detected. 
Conclusion. US examination appears 
to be a useful imaging technique to 
study joint and soft tissue involvement 
in connective tissue diseases. The pres-
ence of bone erosions in pSS patients is 
unexpected. Future studies will hope-
fully concentrate more on defining the 
erosive capability of connective tissue 
disorders together with inflammatory 
involvement of tendons.
Introduction
Primary Sjögren’s syndrome (pSS) is 
an autoimmune inflammatory disorder 
characterized by exocrine glandular 
involvement and extra-glandular mani-
festations such as arthralgia, arthritis, 
myalgia, neuropathy, vasculitis, pulmo-
nary, renal and gastrointestinal disease. 
Several studies report a high prevalence 
of arthralgia in pSS whilst the preva-
lence of true arthritis is still under de-
bate (1-3). Reports vary between studies 
and it has been shown that arthritis oc-
cured in 24% and in 17.6% respectively 
of 110 and 102 subjects with pSS (1, 4, 
5). Furthermore, according to Tzioufas 
et al., 50% of pSS patients experience 
episodes of arthritis at some stage dur-
ing the course of the disease (6). 
Musculoskeletal ultrasound (US) plays a 
key role in the assessment of joints and 
tendons in rheumatic diseases (7-15). To 
date only one study has evaluated articu-
lar involvement in pSS using sonograph-
ic examination of the knee joint (16).
The aim of our study is to investigate 
the US features in the hand in patients 
with pSS.
Patients and methods 
We performed a multicentre study in 4 
different Rheumatology Units in Italy: 
University of Pisa, University of Pavia, 
Università Politecnica delle Marche 
and the Sapienza University of Rome. 
In each unit, US examinations were 
performed by a rheumatologist expe-
rienced in musculoskeletal US using 
a Logiq 9 (General Electrics Medical 
Systems, Milwaukee, WI) with a linear 
probe operating at 14 MHz. The inter-
observer agreement of sonographers in 
detecting and scoring US features of 
joint inflammation and bone erosions 
has been previously calculated and re-
ported in a recent study (17). Good-to- 
excellent agreement rates were found 
in the detection and semiquantitative 
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assessment of US signs of both joint 
inflammation and bone erosions, and 
good agreement rates between sono-
graphers were also found in the detec-
tion of tenosynovitis.
Patients
Forty-eight patients (3 males and 45 fe-
males, mean age: 57 years, ranging from 
81 to 24 years; mean disease duration: 
4.7 years, ranging from 1 to 31 years) 
with pSS were enrolled in the study. The 
diagnosis of pSS was established ac-
cording to the preliminary classification 
criteria proposed by the American-Eu-
ropean Classification Criteria (AECC) 
Group (18). At the time of the US ex-
amination, 31 out of 48 (64.5%) patients 
complained of pain in the hands and 12 
out of 48 (25%) also showed swell-
ing of metacarpophalangeal (MCP) or 
proximal interphalangeal (PIP) joints. 
However, a history of painful hands was 
mentioned by 47 out of 48 patients. 
After informed consent was obtained, 
serum samples were taken from the pa-
tients and immediately stored at -20°C 
until tested for IgG antibodies to viral 
citrullinated peptides (VCP) (19), rheu-
matoid factor (RF), antinuclear anti-
bodies and antibodies to Ro(SSA) and 
La(SSB) antigens. Only patients nega-
tive for anti VCP antibodies were eligi-
ble for the study. Moreover, all the pa-
tients were submitted to minor salivary 
gland biopsy. Focus score ≥1 was de-
tected  in 40 patients (grade 3 and 4 ac-
cording the Chisholm and Mason scor-
ing) (20). Patients with a focus score <1 
were positive for antibodies to Ro(SSA) 
and La(SSB) antigens and fulfilled the 
AECC criteria. The clinical character-
istics of the patients are summarized in 
Table I. 
Control group
As controls we enrolled 40 healthy 
volunteers (3 males and 37 females) 
with mean age 52 years, max. 75 and 
min. 28 years.
US assessment
Bilateral US examination of the 1st – 5th 
MCP, 2nd – 5th PIP joints and of flexor 
tendons were performed using a multi-
planar scanning technique. Joint effu-
sion, synovial hypertrophy, bone ero-
sion and tenosynovitis were diagnosed 
by US according to the preliminary 
definitions provided by the Outcome 
Measures in Rheumatoid Arthritis Clini-
cal Trials (OMERACT) Special Interest 
Group for Musculoskeletal Ultrasound 
in Rheumatology (21). A semi-quanti-
tative grading method (0 to 3) for scor-
ing joint effusion, synovial proliferation 
and intra-articular power Doppler (PD) 
signal was used (17, 22-24).
Statistical analysis
Qualitative variables were compared 
using contingency table analysis and 
Fisher’s exact test. P-values <0.05 were 
considered statistically significant.
Results
pSS patients 
In 20 out of 48 (41.6%) patients US 
examination disclosed joint effusion 
with or without synovial proliferation. 
More precisely, we observed synovial 
proliferation (grade 2) with joint effu-
sion in at least one MCP or PIP joint in 
4 out of 48 (8.3%) patients and in 3 of 
them also a positive PD signal. Osteo-
phytes were not imaged in any of the 4 
patients, but in 1 of them bone erosions 
(at the 2nd and 5th metacarpal heads) 
were visualized. Only one of the 4 pa-
tients was positive for RF; both auto-
antibodies to Ro(SSA) and La(SSB) 
were present in another patient, while 
only anti Ro(SSA) antibodies were de-
tected in the last two subjects. 
In 5 other patients, synovial prolifera-
tion (grade 1) with joint effusion, but 
no PD signal, was visualized at MCP 
and PIP joints with no evidence of os-
teoarthritic change.
In the remaining patients we imaged only 
mild effusion without signs of synovial 
hypertrophy in 11 out of 20. Bony irregu-
larities due to osteoarthritis were present 
in 2 subjects within this last group.
In 10 out of 48 (20.8%) patients we ob-
served flexor tendon effusion with syn-
ovial hypertrophy but no PD signal.
Bone erosions at MCP and/or PIP were 
visualized in 6 out of 48 (12.5%) pa-
tients and in 5 of them features of in-
flammatory arthritis were not detected 
by US. In addition, there was no US ev-
idence of osteoarthritis change in any 
of these 6 individuals who had hand 
pain or gave a history. Laboratory tests 
revealed positivity for RF in 5 of the 
6 subjects, both antibodies to Ro(SSA) 
and La(SSB) in 1 out of 6 and only an-
tibodies to Ro(SSA) in 4 patients.
Pathological findings detected by US 
examination of hand in pSS patients 
are reported in Table II.
Healthy control group
In the group of healthy controls mini-
mal effusion without synovial prolif-
eration at MCP or PIP was discovered 
in 12 out of 40 (30%) subjects. There 
was no significant difference in the 
frequency of effusion without synovial 
proliferation in pSS and the control 
group (p=0.27). In 2 other individuals, 
who also showed osteoarthritic change, 
mild effusion at MCP or PIP was as-
sociated to slight synovial proliferation 
but no PD signal. 
No bone erosions were detected in any 
controls
Flexor tenosynovitis was visualized in 
2 out of 40 (5%) normal subjects. 
The frequency of tenosynovitis in pSS 
patients is higher than in healthy con-
trols (20.8% vs. 5%, p=0.057) with a 
statistically significant trend.
Table I. Main characteristics of patients with pSS.
Patient number M/F Mean age Rheumatoid factor  Antibodies to VCP Positive lip biopsy Antibodies to 
  years (range) (prevalence %) (prevalence %) Focus score≥1 Ro(SSA)±La(SSB) 
     (prevalence %) (prevalence %)
48 3/45 57 (81-24) 28/48 (58%) 0/48 (0%) 40/48 (83%) 29/48 (60%)
M/F: male/female ratio; VCP: viral citrillinated peptides.
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Discussion
Articular signs and symptoms are fre-
quent in pSS. The true prevalence of 
joint and tendon involvement in this 
connective tissue disorder remain un-
clear. In 1993, Pease et al. reviewed 
the clinical course of 48 pSS patients 
and reported that the incidence of ar-
thritis and/or arthralgia was 54% and in 
a third of these patients it was the pre-
senting feature prior to the sicca syn-
drome (25). A study in elderly patients 
revealed that articular involvement was 
present in 29% of the subjects (26). 
Furthermore, arthritis was reported in 
12.5% and 9.8% of patients with early 
and late onset pSS respectively (27). 
Kruize et al. failed to observe arthritis 
(4) in a small number of subjects fol-
lowed longitudinally (1, 5).
Important advances have been made 
in the field of musculoskeletal US 
confirming its eminent position in the 
detailed depiction of the anatomical 
changes in joints and tendons in rheu-
matic disorders. The study by Iagnocco 
et al. remains the pivotal study using 
US to investigate focal joint involve-
ment in pSS describing the presence of 
synovial thickening and slight synovi-
tis within the knee (16). 
Our study showed a high proportion of 
patients with pSS reporting hand pain. 
Subsequent US examination showed 
clear evidence of inflammatory arthri-
tis in 9 (18.7%) patients. This is con-
sistent with most of the smaller studies 
performed to date (1, 5). Interestingly, 
6 patients had MCP and PIP erosions, 
detected in 5 out of these 6 patients in 
the absence of cardinal signs sugges-
tive of active inflammatory disease. 
The origin of these findings is unclear 
but may represent hallmark features of 
previous inflammatory activity within 
these particular joints. 
The study by Wright et al. reported ero-
sive changes within the MCP joints of 
patients with systemic lupus erythema-
tosus (SLE) (8 out of 17) (28). Some 
lupus patients may develop arthritis 
with erosive features (the “rhupus” 
hand) but usually radiographs of hands 
in these patients do not reveal erosive 
changes and the disorder is widely 
viewed as being non-erosive. The pres-
ence of bone erosions in both pSS and 
SLE patients is unexpected. US is able 
to visualize even minimal interruptions 
of the bony cortex so the US technique 
is now recognized as an imaging mo-
dality with higher sensitivity than x-
ray in the detection of small erosions 
Table II. Pathological findings detected by US examination of hand in pSS patients.
    no. of patients
Joint effusion with synovial proliferation in at least one MCP  4/48
or PIP joint (grade 2) 
Joint effusion with synovial proliferation in at least one MCP 5/48 
or PIP joint (grade 1) 
Joint effusion without synovial proliferation 11/48
flexor tenosynovitis 10/48
Bone erosions at MCP and/or PIP joints 6/48
Fig. 1.  A. Dorsal longitudinal scan of the 3rd metacarpo-phalangeal joint. Power Doppler technique showing the presence of signal in the fat pad. 
pp: proximal phalanx; m: metacarpal head; et: extensor tendon; *: fat pad
B. Dorsal longitudinal scan of the 1st  metacarpo-phalangeal joint. Gray scale US. pp: proximal phalanx; m: metacarpal head; the arrow indicates an erosion 
C. Dorsal longitudinal scan of the 2nd interphalangeal joint. Gray scale US. pp: proximal phalanx; mp: middle phalanx; °: shows the effusion in the capsula
D. Volar longitudinal scan of the 2nd interphalangeal joint. Gray scale US. pp: proximal phalanx; mp: middle phalanx; ft: flexor tendons; °: shows the 
effusion in the capsula. 
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which evade traditional radiography 
(7, 8, 29). 
Our 6 patients with bone erosion on US 
examination had had regular clinical 
follow up at our Rheumatology Units 
and the typical manifestations of pSS, 
according to the preliminary classifica-
tion criteria proposed by the American-
European Classification Criteria, had 
been observed. None of the 6 patients 
described symmetrical arthritis or had 
rheumatoid nodules. The sonographic 
demonstration of bone erosion might 
however suggest the possibility of co-
existent rheumatoid arthritis or suggest 
the presence of a subset of pSS patients 
with aggressive arthritis. We think that a 
strict US follow-up should be performed 
in pSS patients, particularly when posi-
tive for RF, to establish the more cor-
rect diagnosis and effective therapy in 
order to avoid structural damage. 
A minimal effusion at MCP or PIP, 
without synovial proliferation, was 
visualized in 11 out of 48 pSS patients 
and also in 12 out of 40 healthy sub-
jects with no statistically significant 
difference (30).
Flexor tenosynovitis in pSS patients 
appeared more frequent than in healthy 
subjects but no statistically significant 
difference was detected. Further stud-
ies on larger populations may help to 
clarify the prevalence further. 
US examination appears to be a use-
ful imaging technique to study joint 
and soft tissue involvement in con-
nective tissue diseases. Future studies 
will hopefully concentrate more on 
defining the erosive capability of these 
disorders together with inflammatory 
involvement of tendons. Future com-
parisons between US and MRI could 
be very interesting in the follow-up of 
pSS patients and could help further our 
understanding of this disease. 
Link
For ultrasound images, go to www.
clinexprheumatol.org/ultrasound
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